Injective issues new whitepaper weeks after first U.S. INJ ETF launches
Injective published a new whitepaper outlining its blockchain infrastructure for real-world assets, decentralized trading and artificial intelligence. The release comes nearly two weeks after the first U.S.-listed ETF tracking its native INJ token began trading on Nasdaq. Traders would read the combination of a fresh roadmap and a newly live U.S. ETF wrapper as a modest positive for INJ demand and visibility.